Compression Therapy Market CAGR of 6.1% Forecast 2019 to 2027

Compression Therapy Market: Overview

According to Transparency Market Research's latest report on the global compression therapy market for the historical period 2017-2018 and forecast period 2019-2027, owing to rising sports injuries, increase in the number of orthopedic surgeries, and rapidly growing obese population boost demand for compression therapy products globally. However, lack of favorable reimbursement policies pertaining to vascular disease treatment with compression products would hamper market growth.

According to the report, the global compression therapy market was valued at US$ 3.2 Bn in 2018 and is anticipated to expand at a CAGR of 6.1% from 2019 to 2027

Report Overview: https://www.transparencymarketresearch.com/compression-therapy-market.html

Rising sports injuries boost demand for compression therapy products: Key Drivers

• Compression products are frequently used by athletes and sports persons as these reduce muscle pain, increase mobility, and enhance athletic performance. The most common causes of sports injuries are competitive, recreational or obligatory (physical education) activities. According to the Centers for Disease Control and Prevention (CDC), high school athletes alone account for 2 million injuries, 50,000 doctor visits, and 30,000 hospitalizations in the U.S. each year.

• Hence, health care professionals (chiropractors and physiotherapists) extensively utilize these products for both amateur and professional sport patients and their regular clinic patients. Therefore, increasing number of sports injuries and growing preference by health care professionals are anticipated to increase the uptake of compression therapy products during the forecast period.

Increasing obese population Boost Market Growth
• Obese people are at high risk of developing vascular diseases due to the pressure exerted by the weight of the body on the skin and underlying organs. According to the World Health Organization (2014), the prevalence of obesity had doubled since 1980. The WHO further stated that over 1.9 billion adults aged 18 years and above were reported to be overweight in 2014, of these over 600 million adults were obese. Furthermore, it is estimated that over 35% of the total population was obese in 2016.

• This number is expected to increase during the forecast period. Therefore, rise in the obese population augments the uptake of compression therapy products in order to prevent vascular diseases.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1537

Lack of favorable reimbursement policies to Hamper Market

• Unfavorable reimbursement policies have played a crucial role in the compression therapy industry in the past few years. The treatment of vascular diseases with compression therapy products is expensive and requires large amount of money for follow-ups and monitoring of treatment. Hence, reimbursement is considered to be an essential aspect of the treatment. The Centers for Medicare and Medicaid Services (CMS) provides reimbursement only to patients who have undergone a four-week trial of conservative therapy before opting for intermittent pump.

• Moreover, private insurers are adopting these reimbursement restrictions for compression therapy products to treat vascular disease. This factor is more prominent in developing nations such as India, China, Brazil, and Mexico due to low affordability to purchase highly expensive brand new compression devices.
Global Compression therapy Market: Competitive Landscape

• This report profiles major players in the global compression therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

• The global compression therapy market is highly fragmented, with the presence of a number of international as well as regional players

• Leading players operating in the global
compression therapy market are
o 3M Health Care
o ArjoHuntleigh
o Bio Compression Systems, Inc
o BSN Medical
o Covidien plc
o medi GmbH & Co KG
o PAUL HARTMANN AG
o SIGVARIS MANAGEMENT AG,.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1537

More Trending Reports by Transparency Market Research:

Biosimilars Market: https://www.transparencymarketresearch.com/biosimilars-market.html

Cat Allergy in Humans Market: https://www.transparencymarketresearch.com/cat-allergy-in-humans-market.html

Dermal Filler Market: https://www.transparencymarketresearch.com/us-dermal-filler-market.html

Particle Therapy Market: https://www.transparencymarketresearch.com/particle-therapy-market.html

Physician Dispensed Cosmeceuticals Market: https://www.transparencymarketresearch.com/physician-dispensed-cosmeceuticals-market.html

Contact Us

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.